A Comparison of 2-octyl Cyanoacrylate Skin Adhesive and Polyester Mesh for Wound Closure in Total Knee Arthroplasty, A Randomized Controlled Study
Launched by POORIWAT LERTSURAWAT · Jan 20, 2024
Trial Information
Current as of July 03, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for closing the skin after total knee replacement surgery, a procedure often needed for people with osteoarthritis in their knees. Researchers want to compare a special skin glue called Dermabond used alone versus Dermabond used along with a polyester mesh. The main focus is to see if there’s a difference in how satisfied patients feel about their wound healing, which will be measured using a specific scoring system.
To be eligible for this trial, participants should be between 50 and 80 years old and need total knee surgery due to osteoarthritis. However, people who have had previous knee surgery, have certain skin conditions, or have issues with understanding instructions will not be able to participate. Those who join can expect to have their wounds closed using one of the two methods and will be asked about their satisfaction with the healing process. This study is currently active, but it is not looking for new participants right now.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • OA knee need for Total knee arthroplasty
- • Age 50-80 years old
- Exclusion Criteria:
- • Previous surgery of knee
- • History of Keloid, Scar, Psoriasis at the knee
- • History of contact dermatitis with skin adhesive
- • Cognitive impairment
About Pooriwat Lertsurawat
Pooriwat Lertsurawat is a dedicated clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With a commitment to ethical practices and regulatory compliance, the organization specializes in the design, execution, and management of clinical studies across various therapeutic areas. Leveraging a team of experienced professionals, Pooriwat Lertsurawat aims to facilitate innovation in healthcare while ensuring the highest standards of safety and efficacy in all trials. Through collaboration with leading research institutions and healthcare providers, the sponsor is dedicated to contributing valuable insights to the medical community and enhancing the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Songkhla, , Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported